Background: Pemphigus vulgaris, a chronic mucocutaneous disease, is the most prevalent type of pemphigus which manifests with development of bullae and erosions on skin and mucosal membranes. Objectives: To investigate the potential role of IL-23 in pemphigus vulgaris. Methods: In this study, 30 patients with pemphigus vulgaris and 30 healthy individuals were selected according to inclusion and exclusion criteria. Measurement of IL-23 serum levels in blood samples was conducted by ELISA. Data was analyzed using Student’s t-test for comparison of IL-23 levels between the two groups. Results: Mean serum levels of IL-23 in patients with pemphigus and healthy controls were 25.1 ± 4.2 and 17.9 ± 4.7 pg/ml, respectively (p<0.05). Conclusions: Based on the findings of this study, serum levels of IL-23 were higher in patients with pemphigus in comparison to healthy individuals with no clinical significance.
Pouralibaba, F., Babaloo, Z., Pakdel, F., Abdollahian, T. & Pourzare, S. (2012). Elevated Levels of Interleukin-23 in Sera of Patients with Pemphigus Vulgaris. Iranian Journal of Immunology, 9(4), 261–265. https://doi.org/10.22034/iji.2012.16880
MLA
Pouralibaba, F., Babaloo, Z., Pakdel, F., Abdollahian, T., & Pourzare, S. "Elevated Levels of Interleukin-23 in Sera of Patients with Pemphigus Vulgaris", Iranian Journal of Immunology, 9, 4, 2012, 261–265. doi: 10.22034/iji.2012.16880
HARVARD
Pouralibaba, F., Babaloo, Z., Pakdel, F., Abdollahian, T., & Pourzare, S. (2012). 'Elevated Levels of Interleukin-23 in Sera of Patients with Pemphigus Vulgaris', Iranian Journal of Immunology, 9(4), pp. 261–265. doi: 10.22034/iji.2012.16880
CHICAGO
Pouralibaba, F., Babaloo, Z., Pakdel, F., Abdollahian, T. & Pourzare, S., "Elevated Levels of Interleukin-23 in Sera of Patients with Pemphigus Vulgaris." Iranian Journal of Immunology, 9 4 (2012): 261–265, doi: 10.22034/iji.2012.16880
VANCOUVER
Pouralibaba F., Babaloo Z., Pakdel F., Abdollahian T., Pourzare S. Elevated Levels of Interleukin-23 in Sera of Patients with Pemphigus Vulgaris. Iran.J.Immunol. 2012;9(4):261–265. doi: 10.22034/iji.2012.16880